Explore
Validate
Learn18283-1-AP
antibody from Proteintech Group
Targeting: CD93
C1qR(P), C1QR1, C1qRP, CDw93, dJ737E23.1, ECSM3, MXRA4
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 18283-1-AP - Provider product page
- Provider
- Proteintech Group
- Product name
- CD93 antibody
- Antibody type
- Polyclonal
- Description
- CD93 antibody (Cat. #18283-1-AP) is a rabbit polyclonal antibody that shows reactivity with human and has been validated for the following applications: IHC, ELISA.
- Reactivity
- Human
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Efferocytosis-related signatures identified via Single-cell analysis and machine learning predict TNBC outcomes and immunotherapy response.
Topical transdermal administration of lenalidomide nanosuspensions-based hydrogels against melanoma: In vitro and in vivo studies.
Wei L, Wen S, Dang T, Zeng T, Yang S, You Y, Tang J, Sun H, Zhang L, Li Q, Li X, Sun M, He X, Zhao L, Zhu X, Zhang Y
Scientific reports 2025 Nov 6;15(1):38955
Scientific reports 2025 Nov 6;15(1):38955
Topical transdermal administration of lenalidomide nanosuspensions-based hydrogels against melanoma: In vitro and in vivo studies.
Zhang M, Qiu H, Han Z, Ma Y, Hou J, Yuan J, Jia H, Zhou M, Lu H, Wu Y
International journal of pharmaceutics: X 2025 Jun;9:100316
International journal of pharmaceutics: X 2025 Jun;9:100316
No comments: Submit comment
No validations: Submit validation data